Asset Management One
AXDX

Asset Management One’s Accelerate Diagnostics AXDX Stock Holding History

Asset Management One’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,418
Closed -$450K – 1049
2021
Q1 		$450K Buy
5,418
+1,474
+37% +$150K ﹤0.01% 925
2020
Q4 		$288K Buy
3,944
+1,435
+57% +$128K ﹤0.01% 926
2020
Q3 		$268K Hold
2,509
– – ﹤0.01% 933
2020
Q2 		$380K Buy
2,509
+602
+32% +$59.4K ﹤0.01% 906
2020
Q1 		$159K Hold
1,907
– – ﹤0.01% 963
2019
Q4 		$322K Hold
1,907
– – ﹤0.01% 970
2019
Q3 		$354K Hold
1,907
– – ﹤0.01% 965
2019
Q2 		$436K Hold
1,907
– – ﹤0.01% 977
2019
Q1 		$401K Buy
1,907
+900
+89% +$169K ﹤0.01% 971
2018
Q4 		$116K Buy
1,007
+216
+27% +$32K ﹤0.01% 1020
2018
Q3 		$182K Buy
791
+324
+69% +$71.6K ﹤0.01% 1032
2018
Q2 		$104K Buy
467
+85
+22% +$19K ﹤0.01% 1055
2018
Q1 		$87K Buy
382
+55
+17% +$14.4K ﹤0.01% 1049
2017
Q4 		$86K Buy
+327
New +$76.7K ﹤0.01% 984

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Asset Management One's AXDX Position: Q2 2021 in Review

Asset Management One sold out of Accelerate Diagnostics (AXDX) in Q2 2021, closing a stake of 5,418 shares — an estimated $450K sold.

Asset Management One first reported a position in AXDX in Q4 2017 and held it in 14 quarters. The position peaked at $450K in Q1 2021. 95 funds tracked by Wall St. Rank hold AXDX as of Q2 2021.

  • Asset Management One reported no remaining Accelerate Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Asset Management One sold 5,418 Accelerate Diagnostics shares in Q2 2021, an estimated $450K.
  • Asset Management One first reported a position in Accelerate Diagnostics in Q4 2017 and held it in 14 quarters.
  • Asset Management One's Accelerate Diagnostics position peaked at $450K in Q1 2021.
  • 95 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2021.

Based on Asset Management One's 13F filing for Q2 2021, filed 3 Aug 2021.